Russian health authorities are monitoring 197 people and investigating the circumstances surrounding the death of a young employee at the Irkutsk Plague Control Institute, after suspicions that her death was linked to a highly dangerous infection that may have been pneumonic plague. The incident prompted precautionary isolation for contacts and the temporary quarantine of a hospital department in Siberia’s Irkutsk region, with no signs of illness so far among those identified through contact tracing.
Employee at plague-control institute dies
Alexei Tsydenov, head of the neighbouring Republic of Buryatia, confirmed the death of a woman whose case was potentially linked to plague. Irkutsk authorities initially described the incident as a suspected case of a “highly dangerous infection”, without officially identifying the disease in a detailed announcement.
Estimates of the deceased woman’s age ranged from 27 to 28. She worked at the Irkutsk Plague Control Institute. Russian and international reports said she may have been exposed to the bacteria in the laboratory after an incident involving a test tube containing live bacteria, but this account was not presented in full in a detailed official statement from Russia’s health authorities.
The employee was taken to a hospital in the city of Shelekhov, near Irkutsk, after developing severe respiratory symptoms. Her condition then deteriorated and doctors had to put her on a ventilator before she was declared dead. The nature of her symptoms and her workplace raised fears that she may have had the pneumonic form of plague.
After the death, authorities identified 197 people believed to have been in contact with the patient and placed them under medical observation or precautionary isolation. A department at the hospital where she was treated was also temporarily quarantined, while epidemiological contact tracing began alongside an investigation into the circumstances of the incident and the possible source of the infection.
Irkutsk Governor Igor Kobzev said the identified contacts currently showed no signs of illness, adding that preliminary laboratory results were negative. These initial findings support the assessment that the likelihood of widespread transmission remains remote, although caution is continuing because pneumonic plague can develop rapidly and become dangerous if treatment is delayed.
How pneumonic plague spreads and develops
Plague is a bacterial infection, not a viral disease. It is caused by Yersinia pestis, a bacterium naturally found in some small rodents and the fleas that infest them. The bacterium has continued to exist in natural animal reservoirs despite the disease’s historical association with major epidemics, most notably the pandemic known as the Black Death centuries ago.
According to the World Health Organisation, people can become infected through the bite of an infected flea or by touching the tissues or bodily fluids of an animal or person carrying the bacterium. It can also spread through inhaling respiratory particles released by someone with pneumonic plague, giving this form the ability to pass directly between people. The disease occurs in several main forms.
The most common is bubonic plague, which typically causes painful swelling of the lymph nodes, while septicemic plague occurs when the bacteria spread through the bloodstream. Pneumonic plague affects the lungs and is considered the most concerning form because it can spread through respiratory particles produced by coughing.
The World Health Organisation describes pneumonic plague as capable, under certain conditions, of causing severe epidemics. Unlike typical bubonic plague, its transmission does not necessarily depend on an animal host or flea bites, as the bacteria can pass from a patient to someone nearby through direct exposure to respiratory droplets.
Data from the European Centre for Disease Prevention and Control indicate that the incubation period for pneumonic plague is usually short, generally ranging from 1 to 3 days. Infection may begin with fever, headache and severe weakness before progressing to chest pain, coughing and difficulty breathing, making the first hours of diagnosis and treatment critically important.
The World Health Organisation says the fatality rate for different forms of plague can range from 30% to 100% when the disease is left untreated. The pneumonic and septicemic forms are often fatal if medical intervention does not begin early, because the bacteria spread rapidly and can cause deterioration in bodily and respiratory functions.
Contracting plague today does not inevitably mean death, unlike in past centuries. The disease is caused by bacteria and can be treated with antibiotics. The World Health Organisation and the US Centers for Disease Control and Prevention say early diagnosis and prompt treatment can save patients’ lives.
Although the pneumonic form can spread between people, epidemiological evidence does not indicate that it usually spreads as easily as highly infectious respiratory diseases such as measles, influenza and Covid-19. Transmission generally requires very close proximity to a coughing patient, particularly in the advanced stages when respiratory symptoms intensify.
A scientific review published by a researcher from the US Centers for Disease Control and Prevention concluded that person-to-person transmission of pneumonic plague is usually associated with close contact with a coughing patient. Previous experience has shown that avoiding direct contact and using respiratory protection helped break chains of infection during earlier outbreaks.
An extensive review of the natural history of the plague bacterium reached a similar conclusion. An analysis of 8 documented pneumonic plague outbreaks estimated that each patient transmitted the infection to an average of about 1.3 secondary cases, with substantial variation between settings depending on contact conditions, the speed of case detection and the application of isolation measures.
The review cited incidents in China in which more than 200 people were exposed to contact with patients, without any secondary infections being recorded after quarantine and monitoring were implemented. It also concluded that infection generally requires a person to be face to face and in close proximity to a coughing patient, limiting its ability to spread in chains compared with some respiratory viruses.
These data do not mean that a major outbreak of pneumonic plague is impossible, but they help explain why most recent cases have not developed into widespread epidemic waves. Rapid isolation, the use of protective measures and the provision of antibiotics to patients and exposed contacts play a crucial role in preventing transmission chains from expanding.
In this context, monitoring 197 people in Russia is not evidence that the same number may be infected or that all the contacts were exposed to a high level of risk. When dealing with rare and severe diseases, public health teams generally widen the scope of contact tracing so that no potential case is missed, particularly when the timing of infection or route of exposure is uncertain.
The US Centers for Disease Control and Prevention recommends preventive antibiotics for people who have had sufficiently close and prolonged contact with a patient with pneumonic plague, as well as for those who have directly touched infected tissues or bodily fluids. Preventive treatment usually lasts 7 days, alongside monitoring for symptoms during the period in which the infection might develop.
Latest plague figures and Madagascar outbreak
Human plague cases continue to be recorded in several countries. In an update published on 29 September 2026, the World Health Organisation said most reported cases between 2019 and 2025 came from the Democratic Republic of the Congo and Madagascar, where natural reservoirs of the bacterium persist and human cases occur from time to time.
The United States also records sporadic cases each year, with a recent average of about 7 human cases annually, according to the US Centers for Disease Control and Prevention. These cases are concentrated in parts of the western United States, and most involve bubonic plague rather than the pneumonic form, which can pass directly between people.
Globally, the World Health Organisation recorded 3248 plague cases and 584 deaths between 2010 and 2015. The figures show that the disease has not disappeared, although the availability of diagnosis, antibiotics and monitoring systems has made dealing with it radically different from the historic plague waves.
Madagascar’s 2017 outbreak provides a recent example of pneumonic plague’s ability to spread when suitable conditions exist. Between August and November that year, authorities reported 2348 confirmed, probable or suspected cases, including 202 deaths, while most of the cases involved the pneumonic form.
During the outbreak, cases reached dozens of areas and major cities, but extensive contact-tracing and preventive-treatment campaigns helped contain it. Health workers monitored more than 7,000 contacts, who received preventive antibiotics to stop the infection from developing and prevent its transmission to others.
Madagascar’s experience shows that pneumonic plague can cause large outbreaks, but also demonstrates the effectiveness of rapidly detecting and isolating cases, treating patients, monitoring contacts and giving them preventive treatment. The infection’s ability to spread declines when these measures are introduced early.
The emergence of further outbreaks cannot be ruled out because plague bacteria remain established in natural animal reservoirs in parts of Africa, Asia and the Americas. The World Health Organisation considers the disease a health risk requiring surveillance and preparedness systems to remain capable of detecting and rapidly responding to human cases.
Recent research warns that the emergence of antibiotic-resistant strains, or delayed diagnosis in areas lacking adequate healthcare, could make some outbreaks more difficult to control. A review published in 2024 in the journal npj Vaccines said that the persistence of natural reservoirs and the possibility of drug resistance made the development of more effective vaccines an important area of global health security.
However, the possibility of the Irkutsk incident becoming a global pandemic differs from the possibility of a local outbreak. The initial information concerns a single death suspected of being linked to plague, while authorities moved to trace contacts, none of whom showed symptoms, and their preliminary test results were negative, according to the regional governor.
Pneumonic plague transmission also generally requires close contact and can be limited through isolation, protective measures and antibiotics. These characteristics reduce its ability to spread continuously around the world compared with respiratory viruses such as Covid-19, although the disease’s severity and rapid progression require continued handling with the utmost caution.
Health investigation to identify source of infection
The health investigation is currently focused on identifying the source of the employee’s infection, determining the type of infection that caused her death and verifying the health of all contacts.
The diagnostic, treatment, contact-tracing and isolation tools currently available remain essential to tackling a disease that can be rapidly fatal, but they were not available when plague caused widespread historical epidemics.
